Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin out part of its operations. Executing this effort may create some operational uncertainty inside…
Vivus shares jumped on Wednesday after the company announced a crucial FDA for its supplemental New Drug Application for an improved formulation of Pancreaze.
Merck reported fourth-quarter financial results before the markets opened on Wednesday that were essentially in line with expectations, yet shares retreated in early trading.
Merck is scheduled to release its fourth-quarter financial results before the markets open on Wednesday. Analysts are looking for year-over-year growth on the top and bottom lines.
Insmed is one of the few biotechs not tied to the coronavirus that is making a big move to start out the week. Essentially, the firm reported midstage study results for patients with non-cystic…
Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an effective treatment for the coronavirus.
Teva Pharmaceuticals has been under fire for its role in the opioid crisis and for pricing fixing of some drugs, often at many times their market value. Is there any sign of a turn…
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.